{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:23:00Z","timestamp":1790706180794,"version":"4.1.0"},"reference-count":39,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,5,21]]},"DOI":"10.3233\/jad-181188","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:02:56Z","timestamp":1557831776000},"page":"529-538","source":"Crossref","is-referenced-by-count":6,"title":["Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"69","author":[{"given":"Tomoyasu","family":"Bunai","sequence":"first","affiliation":[{"name":"Department of Biofunctional Imaging, Preeminent Medical Photonics Education & Research Center, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Kakimoto","sequence":"additional","affiliation":[{"name":"PET Medical Application Group, Central Research Laboratory, Hamamatsu Photonics K.K., Hamakita-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuji","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"PET Medical Application Group, Central Research Laboratory, Hamamatsu Photonics K.K., Hamakita-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiro","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Biofunctional Imaging, Preeminent Medical Photonics Education & Research Center, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"},{"name":"Department of Neurology, Shizuoka Institute of Epilepsy and Neurological Disorders, Aoi-ku, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuomi","family":"Ouchi","sequence":"additional","affiliation":[{"name":"Department of Biofunctional Imaging, Preeminent Medical Photonics Education & Research Center, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-181188_ref1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological staging of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-181188_ref2","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JAD-181188_ref3","doi-asserted-by":"crossref","first-page":"re1","DOI":"10.1126\/sageke.2006.6.re1","article-title":"The development of amyloid beta protein deposits in the aged brain","volume":"2006","author":"Thal","year":"2006","journal-title":"Sci Aging Knowledge Environ"},{"key":"10.3233\/JAD-181188_ref4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181188_ref5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181188_ref6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181188_ref7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181188_ref8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.neuroimage.2008.07.053","article-title":"Appearance modeling of 11C PiB PET images: Characterizing amyloid deposition in Alzheimer\u2019s disease, mild cognitive impairment and healthy aging","volume":"43","author":"Fripp","year":"2008","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-181188_ref9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Scholl","year":"2016","journal-title":"Neuron"},{"key":"10.3233\/JAD-181188_ref10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-181188_ref11","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer\u2019s disease","volume":"129","author":"Engler","year":"2006","journal-title":"Brain"},{"key":"10.3233\/JAD-181188_ref12","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/WNL.0b013e3181bacf1b","article-title":"Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls","volume":"73","author":"Scheinin","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-181188_ref13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00259-010-1612-0","article-title":"In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer\u2019s disease","volume":"38","author":"Yokokura","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-181188_ref14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-181188_ref15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","article-title":"Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study","volume":"68","author":"Edison","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JAD-181188_ref16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuroimage.2007.09.020","article-title":"Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer\u2019s disease","volume":"39","author":"Drzezga","year":"2008","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-181188_ref17","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer\u2019s disease: Implications for sequence of pathological events in Alzheimer\u2019s disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.3233\/JAD-181188_ref18","first-page":"689","article-title":"Mini-Mental State Examination (MMSE)","volume":"24","author":"Cockrell","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.3233\/JAD-181188_ref19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2967\/jnumed.110.082057","article-title":"Early 11C-PIB frames and 18F-FDG PET measures are comparable: A study validated in a cohort of AD and FTLD patients","volume":"52","author":"Rostomian","year":"2011","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-181188_ref20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1177\/0271678X16645593","article-title":"Comparability of [(18)F]THK5317 and [(11)C]PIB blood flow proxy images with [(18)F]FDG positron emission tomography in Alzheimer\u2019s disease","volume":"37","author":"Rodriguez-Vieitez","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-181188_ref21","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-181188_ref22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-181188_ref23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1109\/TNS.2002.1039541","article-title":"A new high resolution PET scanner dedicated to brain research","volume":"49","author":"Watanabe","year":"2002","journal-title":"IEEE Trans Nucl Sci"},{"key":"10.3233\/JAD-181188_ref24","first-page":"1528","article-title":"Anatomic standardization: Linear scaling and nonlinear warping of functional brain images","volume":"35","author":"Minoshima","year":"1994","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-181188_ref25","doi-asserted-by":"crossref","first-page":"e25033","DOI":"10.1371\/journal.pone.0025033","article-title":"New computer-aided diagnosis of dementia using positron emission tomography: Brain regional sensitivity-mapping method","volume":"6","author":"Kakimoto","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-181188_ref26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2967\/jnumed.115.166439","article-title":"Age-related sex-specific changes in brain metabolism and morphology","volume":"57","author":"Kakimoto","year":"2016","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-181188_ref27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.10669","article-title":"Limbic hypometabolism in Alzheimer\u2019s disease and mild cognitive impairment","volume":"54","author":"Nestor","year":"2003","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-181188_ref28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","article-title":"Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease. FDG-PET studies in MCI and AD","volume":"32","author":"Mosconi","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-181188_ref29","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00259-008-0833-y","article-title":"Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer\u2019s disease","volume":"35","author":"Li","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-181188_ref30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000085857","article-title":"Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: Metabolic index and perfusion index","volume":"20","author":"Dobert","year":"2005","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-181188_ref31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11604-007-0132-8","article-title":"Direct comparison study between FDG-PET and IMP-SPECT for diagnosing Alzheimer\u2019s disease using 3D-SSP analysis in the same patients","volume":"25","author":"Nihashi","year":"2007","journal-title":"Radiat Med"},{"key":"10.3233\/JAD-181188_ref32","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2169\/internalmedicine.54.4295","article-title":"The possible link between GABAergic dysfunction and cognitive Decline in a patient with idiopathic hypoparathyroidism","volume":"54","author":"Terada","year":"2015","journal-title":"Intern Med"},{"key":"10.3233\/JAD-181188_ref33","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3233\/JAD-170591","article-title":"In vivo depiction of alpha7 nicotinic receptor loss for cognitive decline in Alzheimer\u2019s disease","volume":"61","author":"Nakaizumi","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181188_ref34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2967\/jnumed.110.083683","article-title":"Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B","volume":"52","author":"Meyer","year":"2011","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-181188_ref35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00259-011-2051-2","article-title":"Correlation of early-phase 18F-florbetapir (AV-45\/Amyvid) PET images to FDG images: Preliminary studies","volume":"39","author":"Hsiao","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-181188_ref36","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1007\/s00330-014-3311-x","article-title":"Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis","volume":"24","author":"Fu","year":"2014","journal-title":"Eur Radiol"},{"key":"10.3233\/JAD-181188_ref37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/2191-219X-2-63","article-title":"Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner","volume":"2","author":"Huisman","year":"2012","journal-title":"EJNMMI Res"},{"key":"10.3233\/JAD-181188_ref38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2967\/jnumed.118.211532","article-title":"Assessing amyloid pathology in cognitively normal subjects using 18F-flutemetamol PET: comparing visual reads and quantitative methods","volume":"60","author":"Collij","year":"2019","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-181188_ref39","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1212\/WNL.0b013e31823a0ef7","article-title":"Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease","volume":"77","author":"Chen","year":"2011","journal-title":"Neurology"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-181188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:36Z","timestamp":1777370976000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-181188"}},"subtitle":[],"editor":[{"given":"David","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":39,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-181188","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]}}}